Dr. Mark Mcclanahan, M.D
NPI: 1093840811
Total Payments
$25,727
2024 Payments
$469.00
Companies
37
Transactions
331
Medicare Patients
20,662
Medicare Billing
$1.6M
Payment Breakdown by Category
Consulting$20,498 (79.7%)
Food & Beverage$5,180 (20.1%)
Education$49.98 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $20,498 | 16 | 79.7% |
| Food and Beverage | $5,180 | 313 | 20.1% |
| Education | $49.98 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $20,735 | 28 | $0 (2024) |
| Zealand Pharma US, Inc. | $674.20 | 37 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $649.75 | 30 | $0 (2020) |
| Valeritas, Inc. | $548.38 | 39 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $508.87 | 82 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $507.96 | 14 | $0 (2023) |
| Lilly USA, LLC | $412.29 | 17 | $0 (2024) |
| Dexcom, Inc. | $218.38 | 12 | $0 (2023) |
| Horizon Therapeutics plc | $187.01 | 5 | $0 (2023) |
| Novo Nordisk Inc | $130.38 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $469.00 | 23 | SANOFI-AVENTIS U.S. LLC ($50.64) |
| 2023 | $318.62 | 14 | BETA BIONICS, INC. ($52.53) |
| 2022 | $341.20 | 14 | Intuity Medical Inc ($124.98) |
| 2021 | $617.96 | 33 | Zealand Pharma US, Inc. ($345.21) |
| 2020 | $628.11 | 33 | Zealand Pharma US, Inc. ($328.99) |
| 2019 | $1,211 | 86 | Valeritas, Inc. ($548.38) |
| 2018 | $5,668 | 73 | SANOFI-AVENTIS U.S. LLC ($4,895) |
| 2017 | $16,474 | 55 | SANOFI-AVENTIS U.S. LLC ($15,654) |
All Payment Transactions
331 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Cardio-renal | ||||||
| 12/19/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: Diabetes Care | ||||||
| 11/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $17.60 | General |
| Category: Insulin Pump | ||||||
| 10/14/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $17.60 | General |
| Category: Insulin Pump | ||||||
| 10/08/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: DIABETES MEDICINE | ||||||
| 09/24/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Endocrinology | ||||||
| 09/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/01/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Diabetes | ||||||
| 07/31/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: Diabetes | ||||||
| 07/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $25.53 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/11/2024 | CeQur Corporation | CeQur Simplicity (Device) | Food and Beverage | Cash or cash equivalent | $32.40 | General |
| Category: Diabetes | ||||||
| 07/10/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/20/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Durable Pump | ||||||
| 05/09/2024 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 05/01/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: DIABETES MEDICINE | ||||||
| 04/25/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/14/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Endocrinology | ||||||
| 03/12/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $34.37 | General |
| Category: Endocrinology | ||||||
| 02/29/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Diabetes Care | ||||||
| 02/23/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $27.17 | General |
| Category: Endocrinology | ||||||
| 02/20/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Endocrinology | ||||||
| 01/24/2024 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $32.39 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/11/2023 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $31.24 | General |
| Category: Automated insulin delivery system | ||||||
| 11/19/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 4,777 | 10,964 | $1.1M | $380,445 |
| 2022 | 12 | 4,977 | 11,400 | $1.1M | $386,466 |
| 2021 | 11 | 5,181 | 11,762 | $1.1M | $414,061 |
| 2020 | 13 | 5,727 | 12,521 | $1.2M | $382,791 |
Total Patients
20,662
Total Services
46,647
Medicare Billing
$1.6M
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 1,348 | 3,152 | $721,808 | $266,356 | 36.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 859 | 2,274 | $90,610 | $21,417 | 23.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 236 | 299 | $44,870 | $18,336 | 40.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 108 | 108 | $44,928 | $15,521 | 34.5% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 238 | 595 | $83,300 | $14,875 | 17.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 848 | 2,261 | $13,566 | $13,295 | 98.0% |
| 77085 | Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment | Office | 2023 | 206 | 206 | $45,150 | $10,494 | 23.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 65 | 74 | $21,712 | $8,246 | 38.0% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 761 | 1,872 | $17,148 | $7,126 | 41.6% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2023 | 30 | 31 | $12,400 | $3,371 | 27.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 78 | 92 | $5,152 | $1,409 | 27.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 1,385 | 3,139 | $718,831 | $268,373 | 37.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 899 | 2,366 | $94,070 | $22,287 | 23.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 260 | 347 | $52,070 | $21,011 | 40.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 131 | 131 | $54,496 | $20,646 | 37.9% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 198 | 512 | $71,680 | $13,374 | 18.7% |
| 77085 | Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment | Office | 2022 | 207 | 207 | $45,540 | $10,568 | 23.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 72 | 76 | $22,278 | $10,082 | 45.3% |
| 82947 | Blood glucose (sugar) level | Office | 2022 | 822 | 2,081 | $19,229 | $7,935 | 41.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 890 | 2,418 | $14,508 | $7,153 | 49.3% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2022 | 29 | 29 | $11,600 | $3,252 | 28.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 71 | 81 | $4,536 | $1,299 | 28.6% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 13 | 13 | $2,080 | $485.84 | 23.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 1,402 | 3,210 | $735,090 | $286,670 | 39.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 155 | 155 | $64,480 | $24,754 | 38.4% |
About Dr. Mark Mcclanahan, M.D
Dr. Mark Mcclanahan, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Fredericksburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/22/2007. The National Provider Identifier (NPI) number assigned to this provider is 1093840811.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Mcclanahan, M.D has received a total of $25,727 in payments from pharmaceutical and medical device companies, with $469.00 received in 2024. These payments were reported across 331 transactions from 37 companies. The most common payment nature is "Consulting Fee" ($20,498).
As a Medicare-enrolled provider, Mcclanahan has provided services to 20,662 Medicare beneficiaries, totaling 46,647 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Fredericksburg, VA
- Active Since 02/22/2007
- Last Updated 04/06/2011
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1093840811
Products in Payments
- PRALUENT (Drug) $20,498
- V-GO (Device) $877.37
- FARXIGA (Drug) $597.92
- JARDIANCE (Drug) $542.00
- JANUVIA (Drug) $343.38
- V-GO DISPOSABLE INSULIN DELIVERY (Device) $308.92
- TEPEZZA (Drug) $187.01
- TRULICITY (Drug) $175.53
- Pogo Automatic Blood Glucose Monitoring System (Device) $124.98
- TOUJEO (Drug) $100.19
- Ozempic (Drug) $99.43
- STEGLATRO (Drug) $96.68
- DEXCOM G6 TRANSMITTER (Device) $68.72
- NATPARA (Drug) $67.20
- Korlym (Drug) $64.40
- UNITHROID (Drug) $64.33
- FREESTYLE LIBRE 3 (Device) $54.01
- iLet Bionic Pancreas (Device) $52.53
- Omnipod (Device) $50.78
- TOUJEO (Biological) $50.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Fredericksburg
Reshma Parab, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $5,669
Endocrinology, Diabetes & Metabolism $5,669
Kehinde Folawewo, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $1,401
Endocrinology, Diabetes & Metabolism $1,401
Dr. Christopher Sonnier, Md, Face, Ecnu, MD, FACE, ECNU
Endocrinology, Diabetes & Metabolism — Payments: $839.92
Endocrinology, Diabetes & Metabolism $839.92